| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/18/2001 | EP1092044A1 IMPROVED METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS |
| 04/18/2001 | EP1092042A1 Method to determine predisposition to hypertension |
| 04/18/2001 | EP1092041A1 Exonuclease-mediated nucleic acid reassembly in directed evolution |
| 04/18/2001 | EP1092039A1 Methods for generating highly diverse libraries |
| 04/18/2001 | EP1092035A2 Targeted integration into chromosomes using retroviral vectors |
| 04/18/2001 | EP1092034A2 Inducible promoters |
| 04/18/2001 | EP1092033A1 Improvements in or relating to plants and plant products |
| 04/18/2001 | EP1092032A2 Human oxidoreductase proteins |
| 04/18/2001 | EP1092031A2 Marburg virus vaccines |
| 04/18/2001 | EP1092030A2 Flt3-l mutants and methods of use |
| 04/18/2001 | EP1092029A1 A novel human thrombopoietin mutein |
| 04/18/2001 | EP1092028A1 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 04/18/2001 | EP1092027A1 Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same |
| 04/18/2001 | EP1092026A2 Neurotransmission associated proteins |
| 04/18/2001 | EP1092025A1 Human emr1-like g protein coupled receptor |
| 04/18/2001 | EP1092024A2 14273 receptor, a g-protein coupled receptor |
| 04/18/2001 | EP1092023A2 Molecules associated with apoptosis |
| 04/18/2001 | EP1092022A2 Immune system molecules |
| 04/18/2001 | EP1092021A1 Npy-y7 receptor gene |
| 04/18/2001 | EP1092020A1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid |
| 04/18/2001 | EP1092019A1 Human homologue of unc-53 protein of c. elegans |
| 04/18/2001 | EP1092018A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 04/18/2001 | EP1092017A1 Novel gaba-b receptor |
| 04/18/2001 | EP1092016A1 TAXOL PRODUCTION VIA GENERATION OF EXTRACHROMOSOMAL DNAs IN THE FUNGUS $i(PESTALOTIOPSIS) |
| 04/18/2001 | EP1092015A2 IN VIVO ADDITION OF TELOMERIC REPEATS TO EXOGENOUS DNA GENERATES EXTRACHROMOSOMAL DNAs IN THE FUNGUS PESTALOTIOPSIS |
| 04/18/2001 | EP1092014A2 Starch debranching enzymes |
| 04/18/2001 | EP1092011A1 DNA ENCODING OAT ACETYL CoA CARBOXYLASE |
| 04/18/2001 | EP1091973A1 Multiparametric fluorescence in situ hybridization |
| 04/18/2001 | EP1091971A2 Polyketides and their synthesis |
| 04/18/2001 | EP1091759A2 Composition for the induction of apoptosis in target cells |
| 04/18/2001 | EP1091739A1 Method for inhibiting c-jun expression using jak-3 inhibitors |
| 04/18/2001 | EP0970126B1 Novel method for the production of antihuman antigen receptors and uses thereof |
| 04/18/2001 | EP0879299A4 High density array fabrication and readout method for a fiber optic biosensor |
| 04/18/2001 | EP0852011A4 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc |
| 04/18/2001 | EP0802795A4 Neurological drug screens |
| 04/18/2001 | EP0796240B1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 04/18/2001 | EP0766566B1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 04/18/2001 | EP0688431B1 Method for screening catalytic non-enzyme polypeptides and proteins |
| 04/18/2001 | EP0657547B1 Method of assaying antithrombin iii activity |
| 04/18/2001 | EP0625572B1 PROCESS FOR SYNTHESIZING COMPLETE-LENGTH cDNA, PROCESS FOR PRODUCING INTERMEDIATE THEREFORE, AND PROCESS FOR PRODUCING RECOMBINANT VECTOR CONTAINING COMPLETE-LENGTH cDNA |
| 04/18/2001 | EP0437579B1 Enhancement of naphthalene dioxygenase activity during microbial indigo production |
| 04/18/2001 | CN1292033A Baculovirus expression system and method for high through put expression of genetic material |
| 04/18/2001 | CN1292032A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/18/2001 | CN1292031A Methods for producing polypeptide in bacillus cell |
| 04/18/2001 | CN1292030A Modified forms of pullulanase |
| 04/18/2001 | CN1292029A Compounds for therapy and diagnosis for lung cancer and method for their use |
| 04/18/2001 | CN1292028A Maltogenic alpha-amylase variants |
| 04/18/2001 | CN1291995A Enhancing circulating half-life of antibody-based fusion proteins |
| 04/18/2001 | CN1291992A Isolated, polypeptides which bind to HLA-A29 molecules, nucleic acid, molecules encoding there, and uses thereof |
| 04/18/2001 | CN1291913A Channel-less separation of bioparticles on bioelectronic chip by dielectrophoresis |
| 04/18/2001 | CN1291860A Particle bombardment transformation of i (brassica) |
| 04/18/2001 | CN1291652A Expression system and application of nutritive methyl pichia pastoris |
| 04/18/2001 | CN1291651A New nucleotide sequence of encode thrE gene and method of producing L-threonine using corynebacterium enzyme |
| 04/18/2001 | CN1291650A Human hepatome derivative growth factor coding sequence, polypeptide coded with it and its preparing process |
| 04/18/2001 | CN1291649A Genetically engineered virus of Chinese ballworm |
| 04/18/2001 | CN1291617A RIM2 protein |
| 04/18/2001 | CN1064710C Therapeutic uses of keratinocyte growth factor |
| 04/18/2001 | CA2321437A1 Dna encoding structural protein-1 of infectious salmon anaemia virus and uses thereof |
| 04/17/2001 | US6218600 Structure and expression of the biotin carboxylase subunit of heteromeric acetyl-CoA carboxylase |
| 04/17/2001 | US6218599 Use as food additive;the oxygenase coverts beta-carotene to canthaxanthin |
| 04/17/2001 | US6218598 Regulatory sequences for the expression of preferential genes |
| 04/17/2001 | US6218597 Genetically engineered rodent for use as models in the treating cardiovascular disorders |
| 04/17/2001 | US6218596 Enhancement of musculature in non-human mammals expressing c-ski |
| 04/17/2001 | US6218595 Genetically engineered cells; for use as test models in the treatment of parkinson's disease or dyskinesis |
| 04/17/2001 | US6218540 Process for preparing camptothecin |
| 04/17/2001 | US6218531 Method of isolating RNA |
| 04/17/2001 | US6218528 MurB |
| 04/17/2001 | US6218527 Nucleotide sequences coding transcription factor; for the generation of transgenic plants that are tolerant to environmental stresses |
| 04/17/2001 | US6218526 Polynucleotide encoding human netrin-1 |
| 04/17/2001 | US6218525 Nucleic acid encoding CD28 |
| 04/17/2001 | US6218524 Nucleotide sequences associated with efficient gene expression; for the detection and treatment of cardiovascular disease |
| 04/17/2001 | US6218523 Nucleotide sequences which can be used to detect adjustment in the genome; for the detection of modulators of preferential gene expression; for diagnosis and treatment of tumors |
| 04/17/2001 | US6218514 Immunoglobulins preferential for a soluble cellular adhesion molecule; for the detection of tumor cells in a sample |
| 04/17/2001 | US6218513 Genetically engineered hemoglobins; for used to treat anemia and hemorrhages; for amplification of cells oxygen carrying capabilities |
| 04/17/2001 | US6218510 Proteins associated with the activation of lymphocytes and monocytes; for treatment of immune defects |
| 04/17/2001 | US6218509 LH/CG receptor, DNA and use thereof |
| 04/17/2001 | US6218508 Anti-microbial proteins |
| 04/17/2001 | US6218506 Soluble brain protein for the detection, prevention and treatment of alzhiemer's disease |
| 04/17/2001 | US6218372 Methods for treating restenosis with p21 |
| 04/17/2001 | US6218370 Useful for cell transfection |
| 04/17/2001 | US6218358 For assaying for functional odor receptors in intact nasal epithelium of mammals such as rats and mice |
| 04/17/2001 | US6218356 Neural receptor tyrosine kinase |
| 04/17/2001 | US6218188 Polynucleotide sequence for expression of pesticide in eukaryotic cells; for biological pest control |
| 04/17/2001 | US6218187 Infect human stem cells with microoganism supernatant; transfect cells, separate cells from supernatant, add adhesion molecules to culture plates, propagate second group of cells with supernantant and recover transduced cells |
| 04/17/2001 | US6218186 HIV-MSCV hybrid viral vector for gene transfer |
| 04/17/2001 | US6218181 Retroviral packaging cell line |
| 04/17/2001 | US6218180 Virion coding a toxic agent, cytokine and tumor suppressor; for the treatment of tumorous defects; antitumor agents |
| 04/17/2001 | US6218179 Nucleotide sequences coding human metallothionein regulatory sequences; for reducing ischemic injury to a cell exposed to hypoxic conditions |
| 04/17/2001 | US6218169 Aromatic amino acid catabolism enzymes |
| 04/17/2001 | US6218168 Process for preparing O-acetylserine, L-cysteine and L-cysteine-related products |
| 04/17/2001 | US6218165 Protease with altered t-cell epitopes; prevents sensitization of individual to protein; detergents; treatment of wool to prevent felting; soaps; cosmetics; skin care |
| 04/17/2001 | US6218164 Thermopallium bacteria and enzymes obtainable therefrom |
| 04/17/2001 | US6218162 SH2-containing inositol-phosphatase |
| 04/17/2001 | US6218161 Dna encoding an active domain of n-acetylgalactosamine-alpha-2,6-sialyltransferase; for recombinant production |
| 04/17/2001 | US6218159 Amino acid sequence; bacteriostats; bactericides; antibiotics; diagnosis of infections; drug screening |
| 04/17/2001 | US6218156 Gene encoding carbonyl reductase, and methods for its use |
| 04/17/2001 | US6218155 Plants and processes for obtaining them |
| 04/17/2001 | US6218152 In vitro amplification of nucleic acid molecules via circular replicons |
| 04/17/2001 | US6218151 Method for nucleic acid amplification by transcription using displacement, and reagents and kit therefor |
| 04/17/2001 | US6218150 Nucleotide and amino acid sequences of thermostable protein; for polymerase chain reactions |